Device-based therapy for decompensated heart failure: An updated review of devices in development based on the...

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Device Development

Background:

• Congestive heart failure (HF) presents significant challenges including hospitalization, morbidity, mortality, and costs.
• Current treatments for decompensated HF involve medications and mechanical cardiac support.
• Emerging devices offer new therapeutic avenues for acute HF decompensation, focusing on symptom relief and organ function recovery.

Purpose of the Study:

• To review a novel classification scheme for new device-based therapies in acute heart failure.
• To describe emerging medical devices designed for acute decompensated heart failure.
• To present the latest preclinical and clinical trial results for these innovative devices.

Main Methods:

• A proposed device-based classification scheme, DRI2P2S, categorizes therapies by mechanism (dilators, removers, inotropes, interstitials, pushers, pullers, selective).
• Review of current literature on preclinical models and clinical trials of new heart failure devices.
• Analysis of device mechanisms including increasing venous capacitance, sodium/water removal, enhancing contractility, lymph removal, and modulating renal pressures.

Main Results:

• The DRI2P2S classification provides a framework for understanding diverse new device mechanisms for acute HF.
• Preclinical and clinical data are emerging for devices targeting various aspects of HF pathophysiology.
• These devices show potential for improving heart and renal function in acute decompensated heart failure patients.

Conclusions:

• Novel device-based therapies are being developed for acute decompensated heart failure.
• The DRI2P2S classification aids in understanding and comparing these new therapeutic approaches.
• Further research and clinical trials are crucial to establish the efficacy and safety of these devices in managing heart failure.